{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:33:15Z","timestamp":1790926395693,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T00:00:00Z","timestamp":1279929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10549-010-1025-6","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T01:44:49Z","timestamp":1279849489000},"page":"31-40","source":"Crossref","is-referenced-by-count":12,"title":["Amplification of the prolactin receptor gene in mammary lobular neoplasia"],"prefix":"10.1007","volume":"128","author":[{"given":"Danh","family":"Tran-Thanh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nona C.","family":"Arneson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Pintilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardit","family":"Deliallisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha S.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Bane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Done","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,24]]},"reference":[{"key":"1025_CR1","first-page":"297","volume":"6","author":"LM Marshall","year":"1997","unstructured":"Marshall LM, Hunter DJ, Connolly JL et al (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297\u2013301","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1025_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","volume":"361","author":"DL Page","year":"2003","unstructured":"Page DL, Schuyler PA, Dupont WD et al (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125\u2013129","journal-title":"Lancet"},{"key":"1025_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","volume":"2","author":"PP Rosen","year":"1978","unstructured":"Rosen PP, Kosloff C, Lieberman PH et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24\u00a0years. Am J Surg Pathol 2:225\u2013251","journal-title":"Am J Surg Pathol"},{"key":"1025_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.amjsurg.2005.01.032","volume":"189","author":"JR Garreau","year":"2005","unstructured":"Garreau JR, Nelson J, Look R et al (2005) Risk counseling and management in patients with lobular carcinoma in situ. Am J Surg 189:610\u2013614; discussion 614\u2013615","journal-title":"Am J Surg"},{"key":"1025_CR5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","volume":"183","author":"WJ Leeuw De","year":"1997","unstructured":"De Leeuw WJ, Berx G, Vos CB et al (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183:404\u2013411","journal-title":"J Pathol"},{"key":"1025_CR6","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","volume":"14","author":"G Berx","year":"1995","unstructured":"Berx G, Cleton-Jansen AM, Nollet F et al (1995) E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107\u20136115","journal-title":"EMBO J"},{"key":"1025_CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/modpathol.3800362","volume":"18","author":"TL Mastracci","year":"2005","unstructured":"Mastracci TL, Tjan S, Bane AL et al (2005) E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 18:741\u2013751","journal-title":"Mod Pathol"},{"key":"1025_CR8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","volume":"76","author":"CB Vos","year":"1997","unstructured":"Vos CB, Cleton-Jansen AM, Berx G et al (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76:1131\u20131133","journal-title":"Br J Cancer"},{"key":"1025_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.pai.0000213128.78665.3c","volume":"15","author":"DJ Dabbs","year":"2007","unstructured":"Dabbs DJ, Kaplai M, Chivukula M et al (2007) The spectrum of morphomolecular abnormalities of the E-cadherin\/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol 15:260\u2013266","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1025_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr1785","volume":"9","author":"TL Mastracci","year":"2007","unstructured":"Mastracci TL, Boulos FI, Andrulis IL et al (2007) Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer. Breast Cancer Res 9:215","journal-title":"Breast Cancer Res"},{"key":"1025_CR11","first-page":"4721","volume":"58","author":"YJ Lu","year":"1998","unstructured":"Lu YJ, Osin P, Lakhani SR et al (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58:4721\u20134727","journal-title":"Cancer Res"},{"key":"1025_CR12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/gcc.20368","volume":"45","author":"TL Mastracci","year":"2006","unstructured":"Mastracci TL, Shadeo A, Colby SM et al (2006) Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosom Cancer 45:1007\u20131017","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR13","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","volume":"100","author":"ES Hwang","year":"2004","unstructured":"Hwang ES, Nyante SJ, Yi Chen Y et al (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100:2562\u20132572","journal-title":"Cancer"},{"key":"1025_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/hupa.2001.22759","volume":"32","author":"JE Etzell","year":"2001","unstructured":"Etzell JE, Devries S, Chew K et al (2001) Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32:292\u2013296","journal-title":"Hum Pathol"},{"key":"1025_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ijc.11460","volume":"107","author":"S Weber-Mangal","year":"2003","unstructured":"Weber-Mangal S, Sinn HP, Popp S et al (2003) Breast cancer in young women (< or = 35\u00a0years): genomic aberrations detected by comparative genomic hybridization. Int J Cancer 107:583\u2013592","journal-title":"Int J Cancer"},{"key":"1025_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-004-4493-8","volume":"90","author":"SK Mohsin","year":"2005","unstructured":"Mohsin SK, O\u2019Connell P, Allred DC et al (2005) Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res Treat 90:249\u2013256","journal-title":"Breast Cancer Res Treat"},{"key":"1025_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.1691","volume":"205","author":"PT Simpson","year":"2005","unstructured":"Simpson PT, Reis-Filho JS, Gale T et al (2005) Molecular evolution of breast cancer. J Pathol 205:248\u2013254","journal-title":"J Pathol"},{"key":"1025_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00428-006-0192-7","volume":"449","author":"L Morandi","year":"2006","unstructured":"Morandi L, Marucci G, Foschini MP et al (2006) Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 449:14\u201323","journal-title":"Virchows Arch"},{"key":"1025_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-007-9557-0","volume":"107","author":"S Aulmann","year":"2008","unstructured":"Aulmann S, Penzel R, Longerich T et al (2008) Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 107:331\u2013335","journal-title":"Breast Cancer Res Treat"},{"key":"1025_CR20","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW et al (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698\u20132708","journal-title":"Cancer"},{"key":"1025_CR21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","volume":"15","author":"N Sneige","year":"2002","unstructured":"Sneige N, Wang J, Baker BA et al (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15:1044\u20131050","journal-title":"Mod Pathol"},{"key":"1025_CR22","unstructured":"Tavassoli FA, Devilee P (2003) Intraductal proliferative lesions. In: Anonymous pathology and genetics. Tumours of the breast and female genital organs. IARC Press, Lyon"},{"key":"1025_CR23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<94::AID-GCC3>3.0.CO;2-W","volume":"18","author":"T Kuukasjarvi","year":"1997","unstructured":"Kuukasjarvi T, Tanner M, Pennanen S et al (1997) Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosom Cancer 18:94\u2013101","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1098-2264(200008)28:4<395::AID-GCC5>3.0.CO;2-J","volume":"28","author":"Q Huang","year":"2000","unstructured":"Huang Q, Schantz SP, Rao PH et al (2000) Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosom Cancer 28:395\u2013403","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/14385","volume":"23","author":"JR Pollack","year":"1999","unstructured":"Pollack JR, Perou CM, Alizadeh AA et al (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23:41\u201346","journal-title":"Nat Genet"},{"key":"1025_CR26","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/1078-0432.CCR-07-4960","volume":"14","author":"VV Iakovlev","year":"2008","unstructured":"Iakovlev VV, Arneson NC, Wong V et al (2008) Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res 14:4446\u20134454","journal-title":"Clin Cancer Res"},{"key":"1025_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/gcc.20711","volume":"48","author":"C Wang","year":"2009","unstructured":"Wang C, Iakovlev VV, Wong V et al (2009) Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes Chromosom Cancer 48:1091\u20131101","journal-title":"Genes Chromosom Cancer"},{"key":"1025_CR28","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116\u20135121","journal-title":"Proc Natl Acad Sci USA"},{"key":"1025_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/JOE-08-0479","volume":"201","author":"ED Galsgaard","year":"2009","unstructured":"Galsgaard ED, Rasmussen BB, Folkesson CG et al (2009) Re-evaluation of the prolactin receptor expression in human breast cancer. J Endocrinol 201:115\u2013128","journal-title":"J Endocrinol"},{"key":"1025_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00428-005-0056-6","volume":"448","author":"GL Bratthauer","year":"2006","unstructured":"Bratthauer GL, Strauss BL, Tavassoli FA (2006) STAT 5a expression in various lesions of the breast. Virchows Arch 448:165\u2013171","journal-title":"Virchows Arch"},{"key":"1025_CR31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02967188","volume":"7","author":"F Satoh","year":"2000","unstructured":"Satoh F, Umemura S, Osamura RY (2000) Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer 7:49\u201355","journal-title":"Breast Cancer"},{"key":"1025_CR32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jcp.54.12.956","volume":"54","author":"S Gill","year":"2001","unstructured":"Gill S, Peston D, Vonderhaar BK et al (2001) Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol 54:956\u2013960","journal-title":"J Clin Pathol"},{"key":"1025_CR33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","volume":"31","author":"DJ Dabbs","year":"2007","unstructured":"Dabbs DJ, Bhargava R, Chivukula M (2007) Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 31:427\u2013437","journal-title":"Am J Surg Pathol"},{"key":"1025_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118\u2013145","journal-title":"J Clin Oncol"},{"key":"1025_CR35","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784\u20132795","journal-title":"J Clin Oncol"},{"key":"1025_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","volume":"24","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV, Furth PA, Hankinson SE et al (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1\u201327","journal-title":"Endocr Rev"},{"key":"1025_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2559.2008.03059.x","volume":"53","author":"M Ferreira","year":"2008","unstructured":"Ferreira M, Mesquita M, Quaresma M et al (2008) Prolactin receptor expression in gynaecomastia and male breast carcinoma. Histopathology 53:56\u201361","journal-title":"Histopathology"},{"key":"1025_CR38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<202::AID-IJC17>3.0.CO;2-B","volume":"79","author":"HC Mertani","year":"1998","unstructured":"Mertani HC, Garcia-Caballero T, Lambert A et al (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79:202\u2013211","journal-title":"Int J Cancer"},{"key":"1025_CR39","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/en.138.12.5555","volume":"138","author":"C Reynolds","year":"1997","unstructured":"Reynolds C, Montone KT, Powell CM et al (1997) Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555\u20135560","journal-title":"Endocrinology"},{"key":"1025_CR40","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/me.16.5.1108","volume":"16","author":"MT Nevalainen","year":"2002","unstructured":"Nevalainen MT, Xie J, Bubendorf L et al (2002) Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Mol Endocrinol 16:1108\u20131124","journal-title":"Mol Endocrinol"},{"key":"1025_CR41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","volume":"127","author":"R Bhargava","year":"2007","unstructured":"Bhargava R, Beriwal S, Dabbs DJ (2007) Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 127:103\u2013113","journal-title":"Am J Clin Pathol"},{"key":"1025_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0303-7207(91)90153-J","volume":"80","author":"Y Myal","year":"1991","unstructured":"Myal Y, Robinson DB, Iwasiow B et al (1991) The prolactin-inducible protein (PIP\/GCDFP-15) gene: cloning, structure and regulation. Mol Cell Endocrinol 80:165\u2013175","journal-title":"Mol Cell Endocrinol"},{"key":"1025_CR43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000132919","volume":"53","author":"KC Arden","year":"1990","unstructured":"Arden KC, Boutin JM, Djiane J et al (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5. Cytogenet Cell Genet 53:161\u2013165","journal-title":"Cytogenet Cell Genet"},{"key":"1025_CR44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.0.CO;2-O","volume":"86","author":"RL Loveday","year":"2000","unstructured":"Loveday RL, Greenman J, Simcox DL et al (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86:494\u2013500","journal-title":"Int J Cancer"},{"key":"1025_CR45","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/1078-0432.CCR-06-1164","volume":"12","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Simpson PT, Turner NC et al (2006) FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 12:6652\u20136662","journal-title":"Clin Cancer Res"},{"key":"1025_CR46","first-page":"4519","volume":"60","author":"F Forozan","year":"2000","unstructured":"Forozan F, Mahlamaki EH, Monni O et al (2000) Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 60:4519\u20134525","journal-title":"Cancer Res"},{"key":"1025_CR47","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.171R001","volume":"171","author":"SK Peirce","year":"2001","unstructured":"Peirce SK, Chen WY, Chen WY (2001) Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 171:R1\u2013R4","journal-title":"J Endocrinol"},{"key":"1025_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10911-008-9068-6","volume":"13","author":"G Swaminathan","year":"2008","unstructured":"Swaminathan G, Varghese B, Fuchs SY (2008) Regulation of prolactin receptor levels and activity in breast cancer. J Mammary Gland Biol Neoplasia 13:81\u201391","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"1025_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01806209","volume":"40","author":"R Das","year":"1996","unstructured":"Das R, Vonderhaar BK (1996) Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 40:141\u2013149","journal-title":"Breast Cancer Res Treat"},{"key":"1025_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjc.6601947","volume":"91","author":"CM Perks","year":"2004","unstructured":"Perks CM, Keith AJ, Goodhew KL et al (2004) Prolactin acts as a potent survival factor for human breast cancer cell lines. Br J Cancer 91:305\u2013311","journal-title":"Br J Cancer"},{"key":"1025_CR51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.onc.1209838","volume":"26","author":"SR Oakes","year":"2007","unstructured":"Oakes SR, Robertson FG, Kench JG et al (2007) Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene 26:543\u2013553","journal-title":"Oncogene"},{"key":"1025_CR52","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/sj.onc.1206619","volume":"22","author":"TA Rose-Hellekant","year":"2003","unstructured":"Rose-Hellekant TA, Arendt LM, Schroeder MD et al (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22:4664\u20134674","journal-title":"Oncogene"},{"key":"1025_CR53","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","volume":"64","author":"SS Tworoger","year":"2004","unstructured":"Tworoger SS, Eliassen AH, Rosner B et al (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814\u20136819","journal-title":"Cancer Res"},{"key":"1025_CR54","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/me.16.7.1696","volume":"16","author":"JL Carsol","year":"2002","unstructured":"Carsol JL, Gingras S, Simard J (2002) Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol Endocrinol 16:1696\u20131710","journal-title":"Mol Endocrinol"},{"key":"1025_CR55","doi-asserted-by":"crossref","first-page":"e4696","DOI":"10.1371\/journal.pone.0004696","volume":"4","author":"MA Debily","year":"2009","unstructured":"Debily MA, Marhomy SE, Boulanger V et al (2009) A functional and regulatory network associated with PIP expression in human breast cancer. PLoS One 4:e4696","journal-title":"PLoS One"},{"key":"1025_CR56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0277-5379(85)90269-X","volume":"21","author":"V Doussal Le","year":"1985","unstructured":"Le Doussal V, Zangerle PF, Collette J et al (1985) Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000. Eur J Cancer Clin Oncol 21:715\u2013725","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1025_CR57","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","volume":"24","author":"LP Middleton","year":"2000","unstructured":"Middleton LP, Palacios DM, Bryant BR et al (2000) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24:1650\u20131656","journal-title":"Am J Surg Pathol"},{"key":"1025_CR58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2559.2000.00810.x","volume":"36","author":"JM Radhi","year":"2000","unstructured":"Radhi JM (2000) Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 36:156\u2013160","journal-title":"Histopathology"},{"key":"1025_CR59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2559.2001.01178.x","volume":"39","author":"AA Selim","year":"2001","unstructured":"Selim AA, El-Ayat G, Wells CA (2001) Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation. Histopathology 39:198\u2013202","journal-title":"Histopathology"},{"key":"1025_CR60","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B","volume":"63","author":"G Mazoujian","year":"1989","unstructured":"Mazoujian G, Bodian C, Haagensen DE Jr et al (1989) Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 63:2156\u20132161","journal-title":"Cancer"},{"key":"1025_CR61","first-page":"3583","volume":"5","author":"WY Chen","year":"1999","unstructured":"Chen WY, Ramamoorthy P, Chen N et al (1999) A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 5:3583\u20133593","journal-title":"Clin Cancer Res"},{"key":"1025_CR62","first-page":"813","volume":"20","author":"NY Chen","year":"2002","unstructured":"Chen NY, Holle L, Li W et al (2002) In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. Int J Oncol 20:813\u2013818","journal-title":"Int J Oncol"},{"key":"1025_CR63","first-page":"3598","volume":"63","author":"MT Beck","year":"2003","unstructured":"Beck MT, Chen NY, Franek KJ et al (2003) Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. Cancer Res 63:3598\u20133604","journal-title":"Cancer Res"},{"key":"1025_CR64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9789-z","volume":"111","author":"ML Scotti","year":"2008","unstructured":"Scotti ML, Langenheim JF, Tomblyn S et al (2008) Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 111:241\u2013250","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1025-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1025-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:20:16Z","timestamp":1559294416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1025-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,24]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1025-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,24]]}}}